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The final word
The content of this Supplement issue reflects our per- text, the early metabolic and pressure control during the
sonal experiences during 40 years of dialysis treatment predialysis conservative period must be emphasized.
in a remarkable way. We have witnessed tremendous Concern about adequate treatment has generated sev-
progress in the treatment of end-stage renal disease eral attempts to quantitate the dose of dialysis. In medi-
(ESRD). However, uremia remains a constellation of cine, the implication of mathematic modeling cannot
signs and symptoms that, in large part, await definitive change human physiology, but human physiology can
elucidation. There is growing awareness that it is the and will imply a necessary change in mathematical mod-
entire spectrum of accumulated products that play a eling. The primary consensus, and one that is also quite
pathophysiological role, rather than an as yet unknown apparent from this Supplement issue, is the use of urea
“uremic toxin.” It is not surprising that the question of as a marker of modeling the dose of dialysis and sodium
what actually constitutes adequate dialysis for ESRD as a marker for models to avoid intradialytic complica-
patients is still a controversial and debated issue within tions. However, a wide discrepancy remains about the
the dialysis community. The term “adequate” may, in interpretation of these modeling approaches.
fact, refer not only to the “dose,” but also to the “systems’ Different cultural backgrounds in the dialysis commu-
biocompatibility,” the reduction of cardiovascular and nity have certainly had an impact on the acceptance
atherosclerotic risk factors, and the minimization of and use of these models in routine clinical application.
chronic inflammation. The previously mentioned attri- However, the inherent danger of misunderstanding and
butes of dialysis adequacy have developed during the therefore misleading such model applications as Kt/V,
last decade as fast-evolving areas of pathophysiological which clearly had an impact on the negative effects of
research in dialysis, and this issue contains contributions shifting dialysis duration, should be taken into serious
from different individuals who have actively participated account. The concept of “dialysis dose,” based on urea
in their development. We, as Guest Editors, avoided kinetic modeling developed by Sargent and Gotch, is a
giving practical guidelines, but felt we should highlight useful and recognized tool used to quantitate and opti-
whatever consensus could be found in the dialysis com- mize a dialysis efficacy program. Although urea mirrors
munity. When this was not possible, we felt that both the behavior of retained low molecular weight and diffus-
sides of the ongoing controversies should be presented, ible solutes, it has no concentration-dependent toxicity,
with the aim of leaving the reader to make a final conclu- and the generation rate of other putative low molecular
sion. We were motivated by the fact that at the turn of weight solutes is not proportional to urea generation.
the new millennium, we all are facing a new era of clinical Furthermore, oversimplification of the “dialysis ade-
medicine that whenever new, more sophisticated investi- quacy” concept of the fractional clearance of body water
gations become available, less and less space will remain by dialysis (Kt/V) might lead to a dramatic state of “un-
for simplistic empiricism. The clinical practice of hemodi- derdialysis,” with its deleterious consequences on mor-
alysis is no exception to this trend. The still unacceptably bidity and mortality of dialysis patients. With this per-
high mortality/morbidity rates in ESRD patients and the spective, the determination of Kt/V must be very
high cost of ESRD management are imperatives for the cautious, relying on accurate measurement of the postdi-
dialysis community to direct all efforts toward a more alysis urea concentration and integrating the Kt/V value
comprehensive understanding of the underlying mecha- as one tool in a quality-assurance process. Provided that
nisms and for possible corrective measures. urea kinetic modeling is correctly used, Kt/V will con-
First, it must be emphasized that uremia per se dam- tinue to be a useful marker of dialysis efficiency that
ages several organs, and prompt adequate therapeutic could be applied to other solutes, such as b2-microglobu-
management of uremia at the predialytic phase will be lin, as our knowledge about uremic toxicity grows.
a major preventive determinant for medium- or long- A general consensus over the problems derived from
term complications in the ESRD population. In this con- oversimplification and its already well-known deleteri-
ous effects has also been gained over the different patho-
physiological factors that have a negative impact on theKey words: hemodialysis, dialysis adequacy, end-stage renal disease,
acute renal failure, multi-organ failure, Kt/V, intensive care medicine. truly delivered dialysis dose, such as access and cardio-
pulmonary recirculation, intercompartmental mass trans-Ó 2000 by the International Society of Nephrology
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fer, dialyzer efficiency, and blood and dialysate flow known. Clinical evaluations showed that conductivity
kinetic models are very precise and accurate, and mayrates. The rather new development of online urea sens-
ing, particularly on the arterial line, has provided a formi- be used instead of sodium kinetic models. Furthermore,
they are suitable for routine use because they do notdable tool for bedside investigation, because—for the
first time—model analysis and validation may be per- require blood sampling or laboratory determinations.
Ongoing studies should provide the confirmatory evi-formed on almost countless measures of urea during the
session. There is certainly no consensus over the benefits dence for their clinical relevance and for the nephrology
community to adopt them on a routine basis.of routine use of the urea sensors. The possibility for a
quick understanding of the various confounding factors What is the ultimate aim that has for so long driven
our efforts to find an easy and inexpensive method ofthat cause a gap between the prescribed and delivered
dose of dialysis as well as the determination of intercom- reaching the desired sodium balance in hemodialysis that
is also suitable for routine application? The answer topartmental mass transfer coefficient is unanimously con-
sidered of great interest and of potential clinical rele- this question is that cardiovascular stability during dial-
ysis is a rational objective to reduce hypertension andvance.
Sodium chloride, the most abundant salt in the extra- hypotension episodes both intradialytically and interdia-
lytically. Hypertension is one of the main determinantscellular fluid, remains the major indicator of body tonic-
ity and determines the distribution of water across the of left ventricular hypertrophy (and later possibly myo-
cardial dilation), and blood pressure control is an essen-intracellular–extracellular boundary, subsequent cell
volume, thirst, and, among patients with renal insuffi- tial part of dialysis treatment, even though in some stud-
ies no clear relationship between blood pressure andciency, systemic blood pressure. In general, hemodialysis
results in inappropriate sodium abstraction or delivery survival has been found. Unfortunately, there is a wide-
spread belief that hypertension is not a cause of thefor .50% of the dialysis population. Proponents of so-
dium modeling believe that delivering comfortable iso- poor prognosis of dialysis patients, mainly because of
the failure of some studies to find any clear relationshipnatric dialysis through closed loop-control systems and
dialysis–ultrafiltration profiling will achieve these goals. between blood pressure and survival.
Cardiovascular disease is the leading cause of mortal-However, there is no agreement on whether the single-
or double-pool model should be used. The validation of ity among patients with ESRD, cardiac disease alone
accounting for 40 to 50% of deaths. The principal alter-a sodium model is difficult because of the relatively small
changes of plasma sodium and the limited precision of ations are left ventricular hypertrophy, decreased elastic-
ity of the large arteries, and atheromatous disease. Leftsodium concentration measurement. Validation of the
predicted volume shifts is also extremely difficult be- ventricular hypertrophy is the consequence of a com-
bined effect of chronic hemodynamic overload, anemia,cause the intracellular volume is not directly accessible
and because the predicted volume shift is small com- and nonhemodynamic biochemical and neurohumoral
factors characteristic of uremia.pared with total intracellular volume. Sodium profiling
has often been claimed to provide a way to ensure better Besides the cardiovascular risk factors present in the
general population, chronic high pressure and volumesodium removal and cardiovascular stability to the point
that many dialysis monitors now incorporate devices for overload are the principal hemodynamic factors associ-
ated with cardiac and vascular remodeling in dialysissodium-ultrafiltration profiling. However, it must be
stressed that none of the published data on the effects patients. Cardiac and vascular alterations evolve in paral-
lel and are tightly interrelated. Left ventricular hypertro-of sodium profiling on dialysis morbidity are conclusive,
and often there is a variance in the findings among them. phy and arteriosclerosis are independent risk factors for
overall and cardiovascular mortality in dialysis patients.Therefore, it is unanimously felt that beyond the clinical
“empiric” and anecdoctal validation of a certain sodium- Left ventricular hypertrophy can be partially reversed
by the control of anemia and blood pressure. Currentlyultrafiltration profiling, no sound evidence for their use-
fulness can be drawn. An interesting approach to sodium available data are insufficient to propose efficient thera-
peutic interventions for reversal of arterial alterations,modeling is the utilization of conductivity modeling. Two
conductivity kinetic models (one for hemodialysis and and controlled studies aimed at the prevention and/or
correction of arterial abnormalities in ESRD patientsone for paired filtration dialysis) have been developed on
the basis of the linear relationship between the sodium are needed.
Nutrition remains a key factor not only during dialyticcontent and conductivity of every saline solution and
plasma water, and according to basic theory for ionic treatment, but also in the predialysis phase. Our possibil-
ities to assess the nutritional status of our patients enabledialysance determination. These models make it possible
to know, at the start of each session, the dialysate conduc- us to individualize the sequenced nutritional guidance
for our patients, as well as to control their metabolism.tivity needed to obtain the desired final plasma water
conductivity or to know the latter when the former is Consensus exists that an albumin level above 3 g/dL is
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mandatory and a high caloric, but well-balanced intake atherosclerosis. The use of sterile dialysate or the abroga-
tion of backfiltration such as in high-volume hemodiafil-is favorable for both life expectancy and quality of life.
Moreover, there will always remain the necessity to tration or double-chamber hemodiafiltration reduce cy-
tokine production and plasma levels of acute phaseadapt the nutritional management to cultural habits and
different conditions. This will certainly also have an im- proteins. There seems to be no need for consensus over
sterile dialysate being an absolute, mandatory need inpact on the model treatment as, for example, a high
albumin losing device could have a detrimental effect in hemodialysis.
The mechanisms of uremia-associated oxidative stresssome parts of the world where necessary protein intake
cannot be assured. are not completely understood. Activation of neutrophils
and complement pathway during hemodialysis with anThere is consensus that a definitive link exits between
the chronic inflammatory state and long-term clinical attendant enhanced reactive oxygen species production
may contribute to oxidative stress. However, the levelssequelae of hemodialysis in ESRD patients. Cardiovas-
cular disease, malnutrition, and anemia are now all inter- of oxidation products in plasma and cell membrane are
elevated even in patients with renal failure prior to thepreted as being linked to inflammatory mechanisms that
may trigger and maintain vascular and tissue damage initiation of dialysis therapy. Oxidation occurs also at
the level of plasma lipids and proteins. As in the casewithin the framework of the so-called acute inflamma-
tory response. Cytokines released from jeopardized tis- of low-density lipoprotein, the ensuing electronegative
product (low-density lipoprotein) acquires a much highersues stimulate the liver to synthesize acute phase proteins
including C-reactive protein (CRP). Plasma levels of proatherogenic property than the native molecule. Oxi-
dative stress may thus result from uremia per se. Plausi-CRP in apparently healthy persons or in persons with
unstable angina constitute an independent risk factor for ble explanations are impaired renal synthesis of antioxi-
dant enzyme (for example, glutathione peroxidase), ironcardiovascular events. Cytokines may also induce the
shut down of albumin synthesis with an attendant fall in supplementation, and restriction of food intake resulting
in the depletion of selenium and glutathione. Recentplasma concentrations, a strong indication for malnutri-
tion. More recently, it has been suggested that CRP is studies have implicated the oxidative stress in the non-
enzymatic biochemistry leading to irreversible proteinuseful not only as a marker of the acute phase response,
but is also involved in the pathogenesis of the disease. modifications. Reactive oxygen species may directly alter
proteins with the eventual formation of oxidized aminoCRP may, in fact, directly interact with the atheroscle-
rotic vessels or ischemic myocardium by activation of acids, such as ortho-tyrosine and methionine sulfoxide.
Alternatively, reactive carbonyl compounds formed bythe complement system, thereby promoting inflamma-
tion and thrombosis; but how can uremia and hemodialy- the oxidation of carbohydrates and lipids may indirectly
lead to advanced glycation or lipoxidation of proteins.sis trigger and maintain a state of chronic inflammation?
Uremia, per se, may induce a state of chronic inflamma- Chronic uremia is associated with increased modification
of protein due to reactive carbonyl compounds derivedtion related to an enhanced predisposition to oxidative
stress. However, the bioincompatibility of the dialytic from both carbohydrates and lipids. Increased carbonyl
modification of proteins subsequently results in the risesystem may also profoundly trigger or aggravate a pre-
existing chronic inflammation. of plasma and tissue contents of advanced glycation end
products and advanced lipoxidation end products, whoseThere is ample evidence and large consensus for the
fact that pyrogenic substances of bacterial origin derived deleterious biological effects have already been revealed.
Since hemodialysis may be a pro-oxidant event, uremia-from contaminated dialysate penetrate intact dialyzer
membranes, with the consequence of the induction of related oxidative effects may be further worsened.
How is the technology in dialysis helpful in approach-an inflammatory response in the patients. The influence
of the dialyzer membrane on the passage of bacterial ing the different pathophysiological aspects? Dialysis
technology has allowed advances in our knowledge insubstances from dialysate into blood depends on the
membrane polymer characteristics, the formation of pro- four main areas: the “dose” quantitation with “blood or
dialysate biosensors,” the use of adsorption in additiontein coating, and the extent of backfiltration. Reaching
the patient’s blood, bacteria-derived substances activate to convection and diffusion, the availability of equipment
for a “clean” dialysis, and finally, the introduction ofcirculating mononuclear cells to produce proinflamma-
tory cytokines. Cytokines such as interleukin-1b and tu- new antioxidative treatments. However, a large number
of accumulated medium to large molecular weight com-mor necrosis factor-a are mediators of the acute phase
response resulting in elevated levels of acute phase pro- pounds are not being removed during hemodialysis or
any other related technique. Whether regeneration ofteins (for example, CRP). The consequence is a state of
microinflammation that may contribute to progressive the membrane filtrate in the future may be oriented to
the ability to selectively adsorb defined “uremic toxins”inflammatory diseases in chronic renal failure, such as
b2-microglobulin amyloidosis, protein catabolism, and awaits the combined definition of their real pathophysio-
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logical role—and therefore of the clinical relevance de- efit analyses, dialysis technology will not be able to fix
“gold standards” in the absence of continuing research inrived from their removal—as well as technological feasi-
the biological mechanisms that contribute to the clinicalbility. Another area of investigation is to implicate
relevance of inadequate dialysis in its broadest term.hemodialysis not only as a “removing/replacing” tech-
The new millennium inspires us to put all of our energynique, but also as a therapy that spares beneficial com-
towards adequately responding to human pathophysiol-pounds normally lost in today’s hemodialysis, thus
ogy and ultimately to the patients’ needs. However, nei-avoiding the progressive shrinking and wasting often ob-
ther research nor technology should overshadow the firstserved in ESRD patients on long-term extracorporeal
absolute requirement in clinical medicine, for which he-
treatment. modialysis is surely no exception: the daily learning and
These are only a few instances in which the combined comprehension at the side of our patients. With the help
efforts of studies on the patient’s pathophysiology and of our contributors, we dedicate this Supplement issue
dialysis technology will provide new insight in the future. to our patients.
We are convinced that hemodialysis needs to remain an
area of intensive research. As pathophysiology may be Giuseppe La Greca, Horst Klinkmann,
sterile and ultimately useless without the prompt con- Fernando Valderra´bano, and Pietro Zucchelli
Guest Editorsfrontation with technological development and cost-ben-
